BNOX
Price
$0.32
Change
+$0.03 (+10.34%)
Updated
Nov 14 closing price
12 days until earnings call
MNPR
Price
$18.23
Change
-$1.00 (-5.20%)
Updated
Nov 14 closing price
Ad is loading...

BNOX vs MNPR

Header iconBNOX vs MNPR Comparison
Open Charts BNOX vs MNPRBanner chart's image
Bionomics
Price$0.32
Change+$0.03 (+10.34%)
Volume$1.91M
CapitalizationN/A
Monopar Therapeutics
Price$18.23
Change-$1.00 (-5.20%)
Volume$115.99K
CapitalizationN/A
BNOX vs MNPR Comparison Chart
Loading...
BNOX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
BNOX vs. MNPR commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BNOX is a StrongBuy and MNPR is a Sell.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (BNOX: $0.32 vs. MNPR: $18.23)
Brand notoriety: BNOX and MNPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BNOX: 15% vs. MNPR: 7%
Market capitalization -- BNOX: $5.49M vs. MNPR: $96.21M
BNOX [@Biotechnology] is valued at $5.49M. MNPR’s [@Biotechnology] market capitalization is $96.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BNOX’s FA Score shows that 0 FA rating(s) are green whileMNPR’s FA Score has 0 green FA rating(s).

  • BNOX’s FA Score: 0 green, 5 red.
  • MNPR’s FA Score: 0 green, 5 red.
According to our system of comparison, MNPR is a better buy in the long-term than BNOX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BNOX’s TA Score shows that 4 TA indicator(s) are bullish while MNPR’s TA Score has 3 bullish TA indicator(s).

  • BNOX’s TA Score: 4 bullish, 5 bearish.
  • MNPR’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, MNPR is a better buy in the short-term than BNOX.

Price Growth

BNOX (@Biotechnology) experienced а -16.63% price change this week, while MNPR (@Biotechnology) price change was +15.89% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

BNOX is expected to report earnings on Nov 27, 2024.

MNPR is expected to report earnings on Nov 08, 2024.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MNPR($96.2M) has a higher market cap than BNOX($5.49M). MNPR YTD gains are higher at: 971.723 vs. BNOX (-78.595).
BNOXMNPRBNOX / MNPR
Capitalization5.49M96.2M6%
EBITDAN/AN/A-
Gain YTD-78.595971.723-8%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A0-
TECHNICAL ANALYSIS
Technical Analysis
BNOXMNPR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
0%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
68%
View a ticker or compare two or three
Ad is loading...
BNOX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MNPR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

BNOX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNOX has been loosely correlated with QLGN. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if BNOX jumps, then QLGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNOX
1D Price
Change %
BNOX100%
+8.20%
QLGN - BNOX
61%
Loosely correlated
-1.46%
ZVSA - BNOX
26%
Poorly correlated
-9.60%
LUMO - BNOX
26%
Poorly correlated
+0.70%
MNPR - BNOX
25%
Poorly correlated
-5.20%
PPBT - BNOX
25%
Poorly correlated
-5.26%
More

MNPR and

Correlation & Price change

A.I.dvisor tells us that MNPR and MPSYF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MNPR and MPSYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNPR
1D Price
Change %
MNPR100%
-5.20%
MPSYF - MNPR
29%
Poorly correlated
N/A
DBVT - MNPR
27%
Poorly correlated
-9.68%
QNCX - MNPR
27%
Poorly correlated
+19.50%
RAPT - MNPR
26%
Poorly correlated
-18.47%
BNOX - MNPR
25%
Poorly correlated
+8.20%
More